Guy G Brusselle Selected Research

Symptom Flare Up

1/2022	Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
1/2022	Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guy G Brusselle Research Topics

Disease

73	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 06/2005
39	Asthma (Bronchial Asthma) 01/2022 - 06/2005
27	Inflammation (Inflammations) 01/2021 - 03/2006
18	Pneumonia (Pneumonitis) 12/2021 - 01/2006
12	Emphysema 01/2021 - 12/2005
5	Respiratory Tract Infections (Respiratory Tract Infection) 01/2020 - 05/2014
4	Symptom Flare Up 01/2022 - 01/2022
4	Eosinophilia 01/2020 - 04/2013
4	Respiratory Hypersensitivity 12/2018 - 03/2006
4	Body Weight (Weight, Body) 05/2015 - 06/2008
3	COVID-19 04/2021 - 01/2020
3	Necrosis 01/2021 - 06/2008
3	Metaplasia 01/2017 - 01/2015
3	Airway Obstruction (Choking) 01/2016 - 06/2014
2	Lung Diseases (Lung Disease) 11/2021 - 11/2017
2	Nasal Polyps (Nasal Polyp) 10/2021 - 01/2021
2	Atrial Fibrillation 04/2021 - 05/2006
2	Heart Failure 04/2021 - 01/2014
2	Airway Remodeling 01/2021 - 01/2015
2	Bacterial Infections (Bacterial Infection) 01/2021 - 09/2011
2	Obesity 01/2021 - 01/2019
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 05/2015
2	Nasopharyngitis 01/2020 - 05/2015
2	Crohn Disease (Crohn's Disease) 01/2020 - 01/2015
2	Genetic Risk Score 01/2017 - 01/2017
2	Bronchiectasis 01/2017 - 01/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 01/2014
2	Obstructive Lung Diseases (Obstructive Lung Disease) 06/2015 - 01/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2014 - 04/2014
2	Respiratory Tract Diseases (Respiratory Tract Disease) 05/2014 - 08/2013
2	Weight Gain 10/2010 - 10/2010
1	Rhinosinusitis 10/2021
1	Hypertension (High Blood Pressure) 04/2021
1	Coronary Disease (Coronary Heart Disease) 04/2021
1	Eczema 01/2021
1	Dementia (Dementias) 01/2021
1	Neoplasms (Cancer) 12/2020

Drug/Important Bio-Agent (IBA)

32	SmokeIBA 12/2021 - 12/2005
17	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 08/2005
16	Proteins (Proteins, Gene)FDA Link 04/2021 - 12/2005
15	Messenger RNA (mRNA)IBA 01/2021 - 12/2005
11	MicroRNAs (MicroRNA)IBA 12/2021 - 04/2011
10	Azithromycin (Zithromax)FDA LinkGeneric 01/2022 - 04/2013
10	CytokinesIBA 01/2021 - 06/2009
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2007
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017 - 03/2011
5	Muscarinic AntagonistsIBA 01/2022 - 02/2016
5	MacrolidesIBA 01/2021 - 01/2014
4	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 01/2022 - 01/2022
4	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 01/2022
4	GoldIBA 12/2021 - 01/2007
4	Interleukin-13IBA 01/2021 - 05/2011
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2019 - 01/2016
4	GasesIBA 01/2018 - 12/2005
3	ChemokinesIBA 12/2021 - 06/2009
3	mepolizumabIBA 10/2021 - 09/2014
3	Interleukin-5 (Interleukin 5)IBA 01/2021 - 09/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2010
3	Bronchodilator Agents (Bronchodilators)IBA 01/2019 - 01/2016
3	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 12/2018 - 02/2016
3	CateninsIBA 01/2017 - 03/2011
3	Pharmaceutical PreparationsIBA 02/2016 - 05/2015
3	EnzymesIBA 01/2015 - 06/2010
3	LeptinIBA 08/2013 - 06/2010
3	Matrix Metalloproteinases (MMPs)IBA 10/2010 - 06/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2008 - 12/2005
2	LigandsIBA 12/2021 - 10/2006
2	Transcription Factors (Transcription Factor)IBA 12/2021 - 03/2019
2	Immunoglobulin E (IgE)IBA 01/2021 - 03/2006
2	ApolipoproteinsIBA 01/2021 - 01/2021
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2013
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	reslizumabIBA 01/2020 - 05/2015
2	Interleukin-33IBA 01/2020 - 12/2018
2	Pancreatic Elastase (Elastase)IBA 01/2017 - 03/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2015 - 04/2014
2	activin AIBA 04/2014 - 03/2010
2	Leptin ReceptorsIBA 08/2013 - 06/2010
2	C-Reactive ProteinIBA 04/2013 - 03/2009
2	Chemokine ReceptorsIBA 06/2007 - 04/2007
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2021
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 12/2021
1	NitratesIBA 04/2021
1	quinoline-val-asp(OMe)-CH2-OPHIBA 01/2021
1	InterleukinsIBA 01/2021
1	Interferon Type IIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2021
1	anti-IgE antibodiesIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 07/2020
1	Protons (Proton)IBA 07/2020
1	Thymic Stromal LymphopoietinIBA 01/2020
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 01/2020

Therapy/Procedure

15	Therapeutics 01/2022 - 08/2005
5	Biological Therapy 01/2022 - 01/2022
1	Bronchial Thermoplasty 01/2021